TY - JOUR
T1 - Optical technologies and molecular imaging for cervical neoplasia
T2 - a program project update
AU - Buys, Timon P. H.
AU - Cantor, Scott B.
AU - Guillaud, Martial
AU - Adler-Storthz, Karen
AU - Cox, Dennis D.
AU - Okolo, Clement
AU - Arulogon, Oyedunni
AU - Oladepo, Oladimeji
AU - Basen-Engquist, Karen
AU - Shinn, Eileen
AU - Yamal, Jose-Miguel
AU - Beck, J. Robert
AU - Scheurer, Michael E.
AU - van Niekerk, Dirk
AU - Malpica, Anais
AU - Matisic, Jasenka
AU - Staerkel, Gregg
AU - Atkinson, Edward Neely
AU - Bidaut, Luc
AU - Lane, Pierre
AU - Benedet, J. Lou
AU - Miller, Dianne
AU - Ehlen, Tom
AU - Price, Roderick
AU - Adewole, Isaac F.
AU - MacAulay, Calum
AU - Follen, Michele
N1 - Copyright 2012 Elsevier B.V., All rights reserved.
PY - 2012/2/1
Y1 - 2012/2/1
N2 - There is an urgent global need for effective and affordable approaches to cervical cancer screening and diagnosis. In developing nations, cervical malignancies remain the leading cause of cancer-related deaths in women. This reality may be difficult to accept given that these deaths are largely preventable; where cervical screening programs have been implemented, cervical cancerrelated deaths have decreased dramatically. In developed countries, the challenges of cervical disease stem from high costs and overtreatment. The National Cancer Institutefunded Program Project is evaluating the applicability of optical technologies in cervical cancer. The mandate of the project is to create tools for disease detection and diagnosis that are inexpensive, require minimal expertise, are more accurate than existing modalities, and can be feasibly implemented in a variety of clinical settings. This article presents the status and long-term goals of the project.
AB - There is an urgent global need for effective and affordable approaches to cervical cancer screening and diagnosis. In developing nations, cervical malignancies remain the leading cause of cancer-related deaths in women. This reality may be difficult to accept given that these deaths are largely preventable; where cervical screening programs have been implemented, cervical cancerrelated deaths have decreased dramatically. In developed countries, the challenges of cervical disease stem from high costs and overtreatment. The National Cancer Institutefunded Program Project is evaluating the applicability of optical technologies in cervical cancer. The mandate of the project is to create tools for disease detection and diagnosis that are inexpensive, require minimal expertise, are more accurate than existing modalities, and can be feasibly implemented in a variety of clinical settings. This article presents the status and long-term goals of the project.
UR - http://www.scopus.com/inward/record.url?scp=84857370792&partnerID=8YFLogxK
U2 - 10.1016/j.genm.2011.08.002
DO - 10.1016/j.genm.2011.08.002
M3 - Article
C2 - 21944317
AN - SCOPUS:84857370792
SN - 1550-8579
VL - 9
JO - Gender Medicine
JF - Gender Medicine
IS - 1 SUPPL.
ER -